Capital Analysts, LLC Viatris Inc Transaction History
Capital Analysts, LLC
- $2.49 Billion
- Q4 2024
A detailed history of Capital Analysts, LLC transactions in Viatris Inc stock. As of the latest transaction made, Capital Analysts, LLC holds 559 shares of VTRS stock, worth $6,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
559
Previous 431
29.7%
Holding current value
$6,367
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
987MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.62 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.06 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$726 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$713 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$668 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...